Literature DB >> 2949609

Presymptomatic testing for Huntington chorea: guidelines for moral and social accountability.

J F Smurl, D D Weaver.   

Abstract

Clinical trials of a presymptomatic test for Huntington chorea (HC) are beginning, and the test may set precedents in screening for other genetic disorders in this way. Therefore, it seems an opportune time to consider the moral and social implications of such testing. The strategy proposed here takes the form of guidelines for research, development, and clinical application of the HC test and any future similar tests. The guidelines cover four stages (preliminary research, verification, refinement, and clinical application). They draw on past experience, on existing guidelines for research involving human subjects, and on some general moral and legal principles. In addition to traditional concerns about relationships between counselors and consultants, they emphasize more contemporary concerns about the interests of third parties and social institutions in what occurs in modern methods of genetic screening. In all cases, however, the guidelines are provisional and are offered here mainly for purposes of discussion and to encourage similar efforts at policymaking by those who become involved with these forms of testing.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  1987        PMID: 2949609     DOI: 10.1002/ajmg.1320260203

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Research on familial Creutzfeldt-Jakob disease (FCJD) resulting in presymptomatic testing: implications for the Human Genome Project.

Authors:  Janet E Ulm; Cindy L Vnencak-Jones; Patrick Bosque
Journal:  J Genet Couns       Date:  1993-03       Impact factor: 2.537

2.  Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?

Authors:  J M Wardlaw; R J Sellar; L J Abernethy
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

3.  Predictive testing for adult-onset genetic disease: ethical and legal implications of the use of linkage analysis for Huntington disease.

Authors:  M A Chapman
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

4.  Considerations in using linkage analysis as a presymptomatic test for Huntington's disease.

Authors:  L A Farrer; R H Myers; L A Cupples; P M Conneally
Journal:  J Med Genet       Date:  1988-09       Impact factor: 6.318

5.  Risk reversals in predictive testing for Huntington disease.

Authors:  E Almqvist; S Adam; M Bloch; A Fuller; P Welch; D Eisenberg; D Whelan; D Macgregor; W Meschino; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.